Clinical Trial Update: An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis [Phase 4]

View source ↗

Summary

Open-label Phase 4 pharmacokinetic study of gabapentin in Japanese subjects with renal impairment including hemodialysis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Impairment

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: PK Properties Of Gabapentin In Subjects With Impaired Renal Function | Phase 4 | Status: TERMINATED